The trial will examine whether VentFree, a neuromuscular electrical stimulator, can reduce the time acute respiratory failure patients spend on mechanical ventilation.
The trial will examine whether VentFree, a neuromuscular electrical stimulator, can reduce the time acute respiratory failure patients spend on mechanical ventilation.
Read More
Liberate Medical has received an FDA emergency use authorization for the VentFree Respiratory Muscle Stimulator, which applies neuromuscular electrical stimulation to the abdominal wall muscles during invasive ventilation.
Read More
The VentFree stimulator applies noninvasive electrical stimulation to the abdominal muscles during exhalation and is intended to prevent abdominal muscle atrophy and reduce mechanical ventilation days.
Read More
A pilot study of Liberate Medical’s VentFree Muscle Stimulator demonstrated its feasibility treating mechanically-ventilated critical care patients, according to ATS 2019 data.
Read More
Liberate Medical’s VentFree muscle stimulator is designed to prevent muscle atrophy and reduce the number of days of ventilator support.
Read More
